AxoGen Analyst & Investor Day Nov 2017
Please join AxoGen executives and physician thought leaders for a discussion of new clinical developments in peripheral nerve repair and the company’s growing platform for nerve repair.
Dr. Kyle Eberlin - Massachusetts General Hospital, Boston, MA
Dr. Constance Chen - Lenox Hill Hospital, New York City, NY
Dr. John Zuniga – UT Southwestern Medical Center, Dallas, TX
Dr. Ivica Ducic - AxoGen Medical Director & Washington Nerve Institute, McLean, VA
Revenue generating, dedicated to peripheral nerve repair with a portfolio of regenerative medicine products available in the US, Canada and several other countries. Products include Avance Nerve Graft, off-the-shelf commercially available processed human nerve allograft for bridging severed nerves without the comorbidities associated with an additional surgical site. 2Q17 Revenue of $15.2M, up 46% compared to $10.4M in 2Q16.